Welcome to our dedicated page for Raymond James SEC filings (Ticker: RJF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Raymond James Financial, Inc. (NYSE: RJF) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI‑powered summaries to help interpret complex documents. Raymond James files a range of forms with the U.S. Securities and Exchange Commission that describe its diversified financial services operations, governance and capital structure.
Investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for detailed information on Raymond James’ Private Client Group, Capital Markets, Asset Management and Bank segments, as well as risk factors, management’s discussion and analysis and notes on capital and liquidity. Current reports on Form 8‑K document material events, such as the announcement of a definitive agreement to acquire Clark Capital Management Group, Inc., the redemption of the firm’s 6.375% Fixed‑to‑Floating Rate Series B Non‑Cumulative Perpetual Preferred Stock and related depositary shares, operating data releases and changes to credit facilities.
The company’s proxy statement on Schedule 14A outlines its mission, core values, corporate governance framework, board composition and executive compensation programs, as well as proposals submitted for shareholder approval. Other filings, such as Form 25 related to the delisting of the Series B preferred depositary shares, provide detail on specific securities and capital actions. Forms 3, 4 and 5, when available, disclose insider ownership and transactions in Raymond James securities.
Stock Titan’s interface surfaces these filings as they are posted to EDGAR and uses AI to highlight key points, explain technical terminology and point out items that may matter to shareholders, such as capital management decisions, segment performance disclosures and governance changes. This allows users to navigate RJF’s 10‑K, 10‑Q, 8‑K, DEF 14A and other forms more efficiently while still being able to drill into the original documents.
Raymond James Financial, Inc. disclosed documentation related to a securities transaction and supporting exhibits. The filing lists depositary shares representing a 1/40th interest in a share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock and an Underwriting Agreement dated September 9, 2025. It references the original Indenture dated August 10, 2009, and Tenth and Eleventh Supplemental Indentures dated September 11, 2025. Forms of 4.900% Senior Notes due 2035 and 5.650% Senior Notes due 2055 are included as exhibits, together with legal opinions and consents, a September 9, 2025 press release, and embedded interactive cover page data. The filing is signed by CFO Jonathan W. Oorlog, Jr.
Haynes Morgan Tarazeta J, Chief Audit Executive of Raymond James Financial (RJF), reported a gift of 114 shares of Raymond James common stock executed on 08/18/2025 (transaction code G) at a reported price of $0.0000. After the transaction the reporting person beneficially owned 3,631 shares directly and 376 shares indirectly through an ESOP account, with the filing noting the ESOP holdings include shares through August 18, 2025. The Form 4 was signed by an attorney-in-fact.
Raymond James Financial, Inc. prospectus supplement for debt securities contains standard offering disclosures, key covenants and investor risk notices. The indenture expressly does not limit the company or its subsidiaries from incurring additional debt, and holders’ remedies are curtailed by a 30-day cure period that applies to interest nonpayment but not to principal or premium, which may delay acceleration rights. The document highlights settlement and market mechanics, including same-day funds settlement for certain notes and the marketwide move to shorter trade settlement cycles (T+1 effective May 28, 2024).
The prospectus explains currency and tax risks for Non-U.S. Dollar-Denominated Securities: depreciation, convertibility limits, governmental controls, and conversion/settlement mechanics may reduce U.S. dollar-equivalent payments. It also details ERISA and Non-ERISA purchaser representations, tax certification requirements for reduced withholding, DTC and book-entry mechanics, and includes unaudited balance-sheet line items as of June 30, 2025 (selected figures shown in the supplement).
Raymond James Financial, Inc. reported a material event in an 8-K dated August 20, 2025 announcing that its Board declared a quarterly cash dividend of $0.3984375 per depositary share on its 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (NYSE: RJF PrB). The dividend is payable October 1, 2025 to holders of record on September 15, 2025. The press release announcing the declaration is furnished as Exhibit 99.1 and is incorporated by reference into the report. The filing notes the exhibit is being "furnished" and not "filed" for purposes of Section 18 of the Exchange Act.
Raymond James Financial Inc. filed a Form 13F-HR reporting its U.S. Section 13(f) equity holdings as of 06-30-2025. The report lists 15,750 information table entries with a total market value of $290,499,498,174. The filing identifies 13 other included managers (subsidiaries and related advisers) by name and Form 13F file number. The signatory is Rachel Jacobson, Manager, Operations, signing on behalf of the reporting manager. The filing notes a change in reporting approach beginning with the quarter ending December 31, 2024: the Reporting Person now uses Form 13F-HR to report positions held by subsidiaries, while subsidiaries with >$100 million under management will file Form 13F-NT and designate the Reporting Person as Other Manager Reporting.
This Form 4 discloses insider activity by Jonathan N. Santelli, identified as Executive Vice President, General Counsel and Secretary of Raymond James Financial, Inc. (RJF). The filing reports a gift transaction dated 08/12/2025 in which 300 shares of RJF common stock were transferred (transaction code G). After the reported transaction, the reporting person beneficially owned 22,579 shares directly. The filing also shows 539 shares held indirectly in an ESOP account, with the explanatory note stating those ESOP shares are included through August 12, 2025. The form is signed by an attorney-in-fact on behalf of Mr. Santelli on 08/14/2025.
The document is a routine Section 16 disclosure showing a non-derivative transfer by gift and the continued beneficial ownership breakdown between direct holdings and an ESOP account. No option grants, exercises, sales, or derivative transactions are reported on this form.
FAQ
What is the current stock price of Raymond James (RJF)?
What is the market cap of Raymond James (RJF)?
